Skip to main
BCPC
BCPC logo

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 17%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Balchem Corp is positioned for continued financial improvement, with expectations for gross and net margins to enhance due to a favorable product mix and robust balance sheet, potentially leading to a debt-free status by next year. The Human Nutrition and Health segment is anticipated to drive accelerated revenue growth, which will contribute to sequential revenue gains in upcoming quarters. Additionally, projections for GAAP earnings indicate a positive trajectory, with estimates rising to $4.01 per share for 2024 and $4.47 for 2025, underscoring the company's strength in high-margin markets.

Bears say

The financial analysis indicates a concerning outlook for Balchem Corp due to a projected decline in earnings, with expected GAAP earnings for full-year 2025 revised down to $4.22 per diluted share from a prior estimate of $4.47. Additionally, there are significant risks associated with the company’s growth trajectory, including potential slowdowns in its base businesses, inflationary pressures, and challenges in launching new products, all of which could impact revenue generation. Furthermore, the company faces external threats related to regional conflicts that may disrupt its European operations, compounding the negatives surrounding its financial performance.

Balchem (BCPC) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 17% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Buy based on their latest research and market trends.

According to 6 analysts, Balchem (BCPC) has a Buy consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $120.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $120.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.